topics

• New and Emerging Modalities in CAR T-Cell Therapies: Differences in Mechanisms, Manufacturing, and Administration
• Real-World Integration of CAR T-Cell Therapy in Rheumatology: Patient Diversity and Eligibility, System and Team Resources, and Collaborative Care
• Evidence of CAR T-Cell Therapy in Rheumatology: Key and Emerging Data from Clinical Trials in Rheumatology

Learning Objectives

• Explain the principles of CAR T-cell therapy in severe autoimmune rheumatic diseases, and compare the mechanisms and modalities of new and emerging CAR T-cell therapies.
• Apply patient factors and disease characteristics to guide eligibility, referral, and treatment selection for CAR T-cell therapy in rheumatic diseases in the future.
• Evaluate current and emerging evidence on the safety, efficacy, and durability of response with CAR T-cell therapies under investigation in rheumatic conditions.
• Incorporate interprofessional strategies to optimize real-world adoption, access, administration, management, and long-term follow-up of CAR T-cell therapies for patients with rheumatic diseases.

CME Information

This activity has been approved for AMA PRA Category 1 Credit(s)™ and MOC Credit.
See the final CE activity announcement for specific details.

Commercial Support:
There is no commercial support for this accredited activity.